Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Zoulim

Showing results (31-40 of 499) with videos related to

Pageof 50
Sort By:
Current Opinion in Virology|July 27, 2017
Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugsLieve Naesens, Fabien Zoulim
La Revue Du Praticien|May 26, 2005
[Treatment of hepatitis C]Vanessa Escuret, Fabien Zoulim
Journal of HIV Therapy|April 9, 2008
Learning from HIV: how will drug resistance influence treatment strategies against hepatitis C?David Durantel, Fabien Zoulim
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistanceFabien Zoulim, Stephen Locarnini
Journal of Hepatology|November 23, 2006
Going towards more relevant cell culture models to study the in vitro replication of serum-derived hepatitis C virus and virus/host cell interactions?David Durantel, Fabien Zoulim
Gut|April 17, 2012
New challenges in viral hepatitisDavid Thomas, Fabien Zoulim
Bulletin Du Cancer|December 28, 2020
[Hepatitis B vaccine and liver cancer]Fanny Lebossé, Fabien Zoulim
Journal of Hepatology|June 26, 2012
Interplay between hepatitis B virus and TLR2-mediated innate immune responses: can restoration of TLR2 functions be a new therapeutic option?David Durantel, Fabien Zoulim
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
How to improve access to therapy in hepatitis B patientsMiroslava Subic, Fabien Zoulim
Hepatology (Baltimore, Md.)|September 5, 2015
Liver capsule: Validated and potential novel targets to treat hepatitis B virusBarbara Testoni, Fabien Zoulim
Pageof 50

Showing results (31-40 of 499) with videos related to

Sort By:
Pageof 50
Current Opinion in Virology|July 27, 2017
Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugsLieve Naesens, Fabien Zoulim
La Revue Du Praticien|May 26, 2005
[Treatment of hepatitis C]Vanessa Escuret, Fabien Zoulim
Journal of HIV Therapy|April 9, 2008
Learning from HIV: how will drug resistance influence treatment strategies against hepatitis C?David Durantel, Fabien Zoulim
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistanceFabien Zoulim, Stephen Locarnini
Journal of Hepatology|November 23, 2006
Going towards more relevant cell culture models to study the in vitro replication of serum-derived hepatitis C virus and virus/host cell interactions?David Durantel, Fabien Zoulim
Gut|April 17, 2012
New challenges in viral hepatitisDavid Thomas, Fabien Zoulim
Bulletin Du Cancer|December 28, 2020
[Hepatitis B vaccine and liver cancer]Fanny Lebossé, Fabien Zoulim
Journal of Hepatology|June 26, 2012
Interplay between hepatitis B virus and TLR2-mediated innate immune responses: can restoration of TLR2 functions be a new therapeutic option?David Durantel, Fabien Zoulim
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
How to improve access to therapy in hepatitis B patientsMiroslava Subic, Fabien Zoulim
Hepatology (Baltimore, Md.)|September 5, 2015
Liver capsule: Validated and potential novel targets to treat hepatitis B virusBarbara Testoni, Fabien Zoulim
Pageof 50